Stock PRTC PURETECH HEALTH PLC
Add to a list
To use this feature you must be a member
Log inSign up

Company PureTech Health plc

Equities

PRTC

GB00BY2Z0H74

Biotechnology & Medical Research

Market Closed - London S.E.
Other stock markets
 11:35:20 2024-04-26 am EDT 		5-day change 1st Jan Change
218 GBX +2.59% Intraday chart for PureTech Health plc +5.06% +12.26%
Apr. 25 Transcript : PureTech Health plc, 2023 Earnings Call, Apr 25, 2024
Apr. 25 PureTech touts "momentum" as grants shrivel but annual loss narrows AN

Business Summary

PureTech Health plc is a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases. The Company's R&D engine has developed 27 therapeutics and therapeutic candidates, including two (Plenity and EndeavorRx) that have received both United States (US) Food and Drug Administration (FDA) clearance and European marketing authorization. The Company's pipeline includes LYT-100, LYT-200, LYT-300, LYT-310 and LYT-503/IMB-150. LYT-100 (deupirfenidone) is being advanced for the potential treatment of conditions involving inflammation and fibrosis. It is developing LYT-200 for the treatment of metastatic/locally advanced solid tumors that have poor survival rates, including urothelial and head and neck cancers. LYT-300 is an oral prodrug of allopregnanolone, which is being advanced for the potential treatment of anxiety disorders and postpartum depression.

Number of employees: 96

Sales per Business

GBP in Million2022Weight2023Weight Delta
Parent Company and Other
51.9 %
0 3.3 % 1 51.9 % +236.22%
Wholly-Owned Programs
25.6 %
2 18.1 % 1 25.6 % -70.09%
Controlled Founded Entities
22.5 %
10 78.1 % 1 22.5 % -93.91%

Sales per region

GBP in Million2022Weight2023Weight Delta
United States
100.0 %
13 100.0 % 3 100.0 % -78.87%

Managers

Managers TitleAgeSince
Eric Elenko FOU
 Founder 51 15-05-31
Daphne Zohar FOU
 Founder 54 15-05-07
Bharatt Chowrira CEO
 Chief Executive Officer 59 17-03-01
Allison Talbot IRC
 Investor Relations Contact - 16-03-31
Anita Terpstra PRN
 Corporate Officer/Principal - -
Aleksandra Filipovic PRN
 Corporate Officer/Principal - 15-08-31
Robert Lyne PRN
 Corporate Officer/Principal 41 Jan. 30

Members of the board

Members of the board TitleAgeSince
Raju S. Kucherlapati CHM
 Chairman 81 13-12-31
Bharatt Chowrira CEO
 Chief Executive Officer 59 17-03-01
Robert Langer FOU
 Founder 75 15-05-07
John LaMattina BRD
 Director/Board Member 74 08-12-31
Kiran Mazumdar-Shaw BRD
 Director/Board Member 71 20-09-30
Daphne Zohar FOU
 Founder 54 15-05-07
Sharon Barber-Lui BRD
 Director/Board Member - 22-03-23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 269,949,741 230,548,603 ( 85.40 %) 0 85.40 %

Shareholders

NameEquities%Valuation
Invesco Asset Management Ltd.
24.04 %
64,945,474 24.04 % 183 M p
Lansdowne Partners (UK) LLP
9.019 %
24,371,115 9.019 % 69 M p
Baillie Gifford & Co.
8.335 %
22,521,433 8.335 % 63 M p
Jupiter Asset Management Ltd.
5.273 %
14,247,071 5.273 % 40 M p
Daphne Zohar
4.705 %
12,712,671 4.705 % 36 M p
M&G Investment Management Ltd.
4.353 %
11,761,956 4.353 % 33 M p
Miller Value Partners LLC
3.714 %
10,035,100 3.714 % 28 M p
Eurizon Capital SGR SpA
3.539 %
9,564,000 3.539 % 27 M p
RECORDATI
3.536 %
9,554,140 3.536 % 27 M p
Patient Capital Management, Inc.
3.516 %
9,500,000 3.516 % 27 M p
NameEquities%Valuation
Pentwater Capital Management LP
0.0379 %
10,244 0.0379 % 291 954 p
Tower Research Capital LLC
0.000159 %
43 0.000159 % 1 226 p
UBS Financial Services, Inc.
0.000074 %
20 0.000074 % 570 p

Company contact information

PureTech Health Plc

6 Tide Street Suite 400

02210, Boston

+617 482 2333

http://www.puretechhealth.com
address PureTech Health plc(PRTC)

Group companies

NameCategory and Sector
Puretech Health LLC
Logo Puretech Health LLC

Puretech Health LLC

Investment ManagersFinance

Puretech Health LLC (PureTech Ventures) is a venture capital subsidiary of PureTech Health Plc founded in 2000 by Daphne Zohar, Robert Langer and Ben Shapiro. The firm is headquartered in Boston, Massachusetts.

Investment Managers

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sales per Business

Ratings for PureTech Health plc

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.655 USD
Average target price
6.205 USD
Spread / Average Target
+133.72%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
PURETECH HEALTH PLC Stock PureTech Health plc
+12.26% 717M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.59B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 40.65B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 40.57B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.77B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 24.81B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.17B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.05B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.7B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11.1B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. PRTC Stock
  4. Company PureTech Health plc